CUSIP 14216R101COMCARMQ4 2025
14 filings · latest Sep 2, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Merck & Co., Inc. | 1.47M | $63.3K |
| 2 | Xtx Topco Ltd | 40.1K | $1.7K |
| 3 | Empowered Funds, LLC | 31.0K | $1.3K |
| 4 | Baader Bank Aktiengesellschaft | 19.5K | $517 |
| 5 | Union Bancaire Privee, Ubp SA | 785 | $28 |
| 6 | Ifp Advisors, Inc | 206 | $9 |
| 7 | Org Partners LLC | 200 | $8 |
| 4 | Apr 25, 2025 | Abbvie Biotechnology Ltd. | 13G/A | 11.0% | 1.86M | SEC |
| 5 | May 28, 2024 | Healthcap Vii, L.P. | 13D/A | 8.2% | 3.40M | SEC |
| 6 | Mar 13, 2024 | Abbvie Biotechnology Ltd | 13G | 6.8% | 2.75M | SEC |
| 7 | Mar 7, 2024 | Healthcap Vii, L.P. | 13D/A | 8.4% | 3.40M | SEC |
| 8 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 3.9% | 1.57M | SEC |
| 9 | Feb 2, 2024 | Longview Innovation Corp. | 13G/A | 6.7% | 2.71M | SEC |
| 10 | Jan 26, 2024 | Trustees Of The University Of Pennsylvania | 13D/A | 3.1% | 1.25M | SEC |
See the full Schedule 13D/13G history for Carisma Therapeutics Inc.
Unlock full history